% | $
Quotes you view appear here for quick access.

pSivida Corp. Message Board

  • godwintom Dec 12, 2013 2:47 PM Flag



    Dr. Paul has written a fair amount in his blogs describing this category of drugs and how they fit into PSDV's plan for the future. Let me attempt to recap this. Bio similar is a drug with close to the same efficacy as the original and bio better is better than the original. Now these drugs become possible when the original drug patent period has expired. At that point, other drug manufacturers or device makers etc. have an opportunity to make a similar or better drug than the original. The concept is simple but the opportunities are enormous, especially when the existing drug is combined with a drug delivery system that blows away the old systems. The delivery platform that is ready and capable of delivering these drugs is Medidur the same system being used in Iluvien & Uveitis. This is what makes PSDV unique, the proven drug delivery system itself, due to it's many advantages over standard oral ingestion, not to mention the tremendous cost advantage of development and renewed patent protection. As Dr. Paul has said there are billions of dollars of sales of various drugs with patents expiring soon plus those that are available right now. It seems to me some people are missing the real potential for PSDV for the near future.JMO

    Sentiment: Strong Buy

    This topic is deleted.
3.69-0.08(-2.12%)Jul 7 4:00 PMEDT